ANNX (STOCKS)
Annexon, Inc. Common Stock
$5.250000
-0.080000 (-1.50%)
Prev close: $5.330000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Douglas Love
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $874.94M
- Employees
- 103
- P/E (TTM)
- -4.65
- P/B (TTM)
- 4.23
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
10
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.23 | $-0.29 | +0.0649 | +22.01% |
|
Dec 2025 (Q4)
|
$-0.28 | $-0.32 | +0.0390 | +12.23% |
|
Sep 2025 (Q3)
|
$-0.37 | $-0.35 | -0.0232 | -6.69% |
|
Jun 2025 (Q2)
|
$-0.34 | $-0.37 | +0.0330 | +8.85% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $205.06M |
| Research and Development | $172.31M |
| Other Operating Expenses | $32.75M |
| Operating Income/Loss | -$205.06M |
| Income/Loss From Continuing Operations After Tax | -$196.48M |
| Income/Loss From Continuing Operations Before Tax | -$196.48M |
| Net Income/Loss | -$196.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$196.48M |
| Net Income/Loss Available To Common Stockholders, Basic | -$198.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.20 |
| Diluted Earnings Per Share | -$1.20 |
| Basic Average Shares | 498,228,947 |
| Diluted Average Shares | 498,228,947 |
| Assets | $262.89M |
| Current Assets | $228.27M |
| Cash | $225.00M |
| Other Current Assets | $3.27M |
| Noncurrent Assets | $34.62M |
| Fixed Assets | $10.11M |
| Other Non-current Assets | $24.52M |
| Liabilities | $58.36M |
| Current Liabilities | $35.94M |
| Accounts Payable | $17.53M |
| Other Current Liabilities | $18.41M |
| Noncurrent Liabilities | $22.42M |
| Equity | $204.53M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $204.53M |
| Liabilities And Equity | $262.89M |
| Net Cash Flow From Operating Activities | -$183.10M |
| Net Cash Flow From Operating Activities, Continuing | -$183.10M |
| Net Cash Flow From Investing Activities | $119.49M |
| Net Cash Flow From Investing Activities, Continuing | $119.49M |
| Net Cash Flow From Financing Activities | $141.69M |
| Net Cash Flow From Financing Activities, Continuing | $141.69M |
| Exchange Gains/Losses | $3.00K |
| Net Cash Flow | $78.09M |
| Net Cash Flow, Continuing | $78.08M |
| Comprehensive Income/Loss | -$196.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$196.47M |
| Other Comprehensive Income/Loss | $158.44M |